Randomized, double-blind, placebo-controlled trial of probiotics combination Clinical research on treatment of colorectal cancer

ABSTRACT: Interventions: Colorectal cancer control group:no;Colorectal cancer probiotics group:No Primary outcome(s): Intestinal flora metabolomics;Intestinal mucosal barrier;Inflammatory factors;Observation of clinical efficacy indicators;Intestinal flora Study Design: Parallel

DISEASE(S): Colorectal Cancer

PROVIDER: 2759602 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR